Supplementary Table from CRISPR/Cas9-Induced DNA Damage Enriches for Mutations in a p53-Linked Interactome: Implications for CRISPR-Based Therapies
Supplementary Table from CRISPR/Cas9-Induced DNA Damage Enriches for Mutations in a p53-Linked Interactome: Implications for CRISPR-Based Therapies
محفوظ في:
| المؤلف الرئيسي: | |
|---|---|
| مؤلفون آخرون: | , , , , , , , |
| منشور في: |
2025
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
| _version_ | 1849927640295669760 |
|---|---|
| author | Long Jiang (14956159) |
| author2 | Katrine Ingelshed (14956162) Yunbing Shen (14956165) Sanjaykumar V. Boddul (14956168) Vaishnavi Srinivasan Iyer (14956171) Zsolt Kasza (14956174) Saikiran Sedimbi (14956177) David P. Lane (128368) Fredrik Wermeling (14956180) |
| author2_role | author author author author author author author author |
| author_facet | Long Jiang (14956159) Katrine Ingelshed (14956162) Yunbing Shen (14956165) Sanjaykumar V. Boddul (14956168) Vaishnavi Srinivasan Iyer (14956171) Zsolt Kasza (14956174) Saikiran Sedimbi (14956177) David P. Lane (128368) Fredrik Wermeling (14956180) |
| author_role | author |
| dc.creator.none.fl_str_mv | Long Jiang (14956159) Katrine Ingelshed (14956162) Yunbing Shen (14956165) Sanjaykumar V. Boddul (14956168) Vaishnavi Srinivasan Iyer (14956171) Zsolt Kasza (14956174) Saikiran Sedimbi (14956177) David P. Lane (128368) Fredrik Wermeling (14956180) |
| dc.date.none.fl_str_mv | 2025-11-24T22:02:07Z |
| dc.identifier.none.fl_str_mv | 10.1158/0008-5472.30698664 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/dataset/Supplementary_Table_from_CRISPR_Cas9-Induced_DNA_Damage_Enriches_for_Mutations_in_a_p53-Linked_Interactome_Implications_for_CRISPR-Based_Therapies/30698664 |
| dc.rights.none.fl_str_mv | CC BY info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Cancer Cancer Biology Molecular and Cellular Biology Therapeutic Research and Development DNA Damage and Repair Drug Targets Oncoprotein & tumor suppressor drug targets Oncogenes & Tumor Suppressors p53 |
| dc.title.none.fl_str_mv | Supplementary Table from CRISPR/Cas9-Induced DNA Damage Enriches for Mutations in a p53-Linked Interactome: Implications for CRISPR-Based Therapies |
| dc.type.none.fl_str_mv | Dataset info:eu-repo/semantics/publishedVersion dataset |
| description | Supplementary Table from CRISPR/Cas9-Induced DNA Damage Enriches for Mutations in a p53-Linked Interactome: Implications for CRISPR-Based Therapies |
| eu_rights_str_mv | openAccess |
| id | Manara_e356eb28e2e15fec3959de2e36078853 |
| identifier_str_mv | 10.1158/0008-5472.30698664 |
| network_acronym_str | Manara |
| network_name_str | ManaraRepo |
| oai_identifier_str | oai:figshare.com:article/30698664 |
| publishDate | 2025 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY |
| spelling | Supplementary Table from CRISPR/Cas9-Induced DNA Damage Enriches for Mutations in a p53-Linked Interactome: Implications for CRISPR-Based TherapiesLong Jiang (14956159)Katrine Ingelshed (14956162)Yunbing Shen (14956165)Sanjaykumar V. Boddul (14956168)Vaishnavi Srinivasan Iyer (14956171)Zsolt Kasza (14956174)Saikiran Sedimbi (14956177)David P. Lane (128368)Fredrik Wermeling (14956180)CancerCancer BiologyMolecular and Cellular BiologyTherapeutic Research and DevelopmentDNA Damage and RepairDrug TargetsOncoprotein & tumor suppressor drug targetsOncogenes & Tumor Suppressorsp53Supplementary Table from CRISPR/Cas9-Induced DNA Damage Enriches for Mutations in a p53-Linked Interactome: Implications for CRISPR-Based Therapies2025-11-24T22:02:07ZDatasetinfo:eu-repo/semantics/publishedVersiondataset10.1158/0008-5472.30698664https://figshare.com/articles/dataset/Supplementary_Table_from_CRISPR_Cas9-Induced_DNA_Damage_Enriches_for_Mutations_in_a_p53-Linked_Interactome_Implications_for_CRISPR-Based_Therapies/30698664CC BYinfo:eu-repo/semantics/openAccessoai:figshare.com:article/306986642025-11-24T22:02:07Z |
| spellingShingle | Supplementary Table from CRISPR/Cas9-Induced DNA Damage Enriches for Mutations in a p53-Linked Interactome: Implications for CRISPR-Based Therapies Long Jiang (14956159) Cancer Cancer Biology Molecular and Cellular Biology Therapeutic Research and Development DNA Damage and Repair Drug Targets Oncoprotein & tumor suppressor drug targets Oncogenes & Tumor Suppressors p53 |
| status_str | publishedVersion |
| title | Supplementary Table from CRISPR/Cas9-Induced DNA Damage Enriches for Mutations in a p53-Linked Interactome: Implications for CRISPR-Based Therapies |
| title_full | Supplementary Table from CRISPR/Cas9-Induced DNA Damage Enriches for Mutations in a p53-Linked Interactome: Implications for CRISPR-Based Therapies |
| title_fullStr | Supplementary Table from CRISPR/Cas9-Induced DNA Damage Enriches for Mutations in a p53-Linked Interactome: Implications for CRISPR-Based Therapies |
| title_full_unstemmed | Supplementary Table from CRISPR/Cas9-Induced DNA Damage Enriches for Mutations in a p53-Linked Interactome: Implications for CRISPR-Based Therapies |
| title_short | Supplementary Table from CRISPR/Cas9-Induced DNA Damage Enriches for Mutations in a p53-Linked Interactome: Implications for CRISPR-Based Therapies |
| title_sort | Supplementary Table from CRISPR/Cas9-Induced DNA Damage Enriches for Mutations in a p53-Linked Interactome: Implications for CRISPR-Based Therapies |
| topic | Cancer Cancer Biology Molecular and Cellular Biology Therapeutic Research and Development DNA Damage and Repair Drug Targets Oncoprotein & tumor suppressor drug targets Oncogenes & Tumor Suppressors p53 |